PDS Biotechnology (PDSB) Return on Equity [ROE] (2015 - 2026)
PDS Biotechnology's Return on Equity [ROE] was -1260.81% in Q2 2026, down 1069.78 percentage points from -191.03% a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at PDS Biotechnology came in at -243.94%, down 77.29 percentage points from FY2024.
- Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -167.47 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -166.65% in FY2024 (-44.19 pp), -122.46% in FY2023 (-46.25 pp), -76.21% in FY2022 (-38.76 pp) and -37.46% in FY2021 (+39.02 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q4 2015.
- Compared with a year earlier, Return on Equity [ROE] was higher in 1 of the last seven quarters, with an average year-over-year change of -209.70 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 49.07 percentage points); the worst was Q2 2026 (a drop of 1069.78 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | -1,260.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,260.81% |
| Dec 31, 2025 | -368.51% |
| Sep 30, 2025 | -274.55% |
| Jun 30, 2025 | -191.03% |
| Mar 31, 2025 | -171.62% |
| Dec 31, 2024 | -183.59% |
| Sep 30, 2024 | -153.28% |
| Jun 30, 2024 | -119.47% |
| Mar 31, 2024 | -138.63% |
| Dec 31, 2023 | -169.68% |
| Sep 30, 2023 | -179.82% |
| Jun 30, 2023 | -130.03% |
| Mar 31, 2023 | -98.91% |
| Dec 31, 2022 | -89.73% |
| Sep 30, 2022 | -56.94% |
| Jun 30, 2022 | -51.40% |
| Mar 31, 2022 | -37.53% |
| Dec 31, 2021 | -25.82% |
| Sep 30, 2021 | -20.77% |
| Jun 30, 2021 | -23.77% |
API Access
PDS Biotechnology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();